Compliance & Enforcement
RA 9711 · CDRRHR enforcement authority · Bureau of Customs · Regional Field Offices
CDRRHR Inspection Authority
CDRRHR has authority to inspect:
- Importer and distributor facilities
- Retail outlets
- Healthcare facility storage and use areas
- Manufacturing facilities (Philippines-based)
CDRRHR inspectors may:
- Request all registration and licence documents
- Sample products for testing
- Review distribution records
- Inspect storage conditions
- Assess labelling compliance
FDA Philippines Enforcement Actions
| Action | Authority |
|---|---|
| Product recall | Order or coordinate recall of non-compliant or unsafe devices |
| CMDN/CMDR suspension | Suspend certificate pending investigation |
| CMDN/CMDR cancellation | Cancel certificate for persistent non-compliance or safety issues |
| LTO suspension | Suspend operations licence |
| LTO revocation | Revoke operations licence |
| Product seizure and condemnation | Seize and destroy unregistered or unsafe devices |
| Fines | Issue fines under RA 9711 |
| Criminal prosecution | Refer serious violations for criminal prosecution |
Prohibited Acts Under RA 9711 and AO 2018-002
The following are prohibited:
- Commercial distribution of unregistered devices (Class A without CMDN; Class B/C/D without CMDR)
- Distribution without a valid LTO
- Falsification or alteration of CMDN or CMDR certificates — PH-Unique criminal provision
- Misrepresentation of device classification
- Distribution of devices that do not match the registered specifications
- Failure to comply with a CDRRHR recall order
Falsification of CMDN/CMDR — PH-Unique
RA 9711 includes specific criminal provisions for falsification or alteration of CMDN or CMDR certificates. This is treated as a serious offence — beyond the civil/administrative penalties available for other violations — and can result in criminal prosecution.
Bureau of Customs Coordination — PH-Unique
The Bureau of Customs (BoC) coordinates with CDRRHR to intercept unregistered medical devices at the point of importation:
- CDRRHR and BoC have a coordinated list of devices requiring valid CMDN/CMDR for customs clearance
- Shipments lacking valid registration documentation may be detained, seized, or returned
- The importer must provide evidence of valid CMDN/CMDR (or confirmation of exemption, as in the case of IVDs) and current LTO for customs release of registered device shipments
Practical implication: Ensure all customs documentation includes the CMDN/CMDR number and the LTO reference. Do not ship without confirmed valid registrations.
Regional Field Offices — PH-Unique
FDA Philippines operates Regional Field Offices throughout the Philippines (outside Metro Manila), which conduct:
- Local compliance monitoring
- Market surveillance sampling
- Inspection of regional importers and distributors
- Consumer complaint investigations
- Coordination with local government units
Geographic reach: Unregistered device distribution is monitored not only in Metro Manila but throughout the archipelago via these regional offices.
Motion for Reconsideration and Appeal — PH-Unique
Under RA 9711, a party aggrieved by a CDRRHR decision (e.g., application disapproval, LTO revocation) may:
- File a Motion for Reconsideration with the FDA Director General within the prescribed period
- Appeal to the Court of Appeals after exhausting administrative remedies
- Further appeal to the Supreme Court on questions of law
This formal appeal process distinguishes Philippines' framework from many other ASEAN markets.
Confidentiality of Submitted Information — PH-Unique
RA 9711 includes provisions on the confidentiality of technical data submitted to FDA Philippines. Proprietary information (formulation details, manufacturing processes, clinical data) submitted for registration purposes is protected from unauthorised disclosure. The FDA may use the information for regulatory evaluation but cannot share it with third parties without the applicant's consent, subject to certain public health exceptions.
Upon issuance of a recall order by CDRRHR, the responsible party (manufacturer, importer, or distributor) must comply within the timeframe specified in the recall notice. Failure to comply or provide evidence of compliance within the prescribed period may result in criminal prosecution, product seizure, facility closure, and/or substantial fines under RA 9711. Maintain documented recall response procedures and communication records with CDRRHR.